PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Feb-2023 Pharma Veteran, Academician and Researcher Cristina Masseria, PhD, MSc to be Head of the Value and Evidence Team at AESARA Businesswire
06-Feb-2023 Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression Businesswire
06-Feb-2023 RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies CluePoints
06-Feb-2023 Profile of Sensoria Health: An Innovator in Wearable Medical Devices for Fitness and Health Care - ResearchAndMarkets.com Businesswire
06-Feb-2023 Slingshot Biosciences Announces $11 Million in Series A3 Financing Businesswire
06-Feb-2023 Data Integrity and Document Management Training Course: Latest MHRA Data Integrity Guide and EMA TMF Guidelines (April 21, 2023) - ResearchAndMarkets.com Businesswire
06-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
05-Feb-2023 La FDA de EE. UU. aprueba TAKHZYRO® (lanadelumab-flyo) de Takeda para prevenir ataques de angioedema hereditario (AEH) en niños de 2 años en adelante Businesswire
05-Feb-2023 FDA dos EUA aprova TAKHZYRO® (lanadelumabe-flyo) da Takeda para prevenir crises de angioedema hereditário (HAE) em crianças com 2 anos de idade ou mais Businesswire
04-Feb-2023 Amerikanische Arzneimittelbehörde FDA genehmigt TAKHZYRO® (Lanadelumab-flyo) von Takeda zur Verhinderung von Attacken des hereditären Angioödems (HAE) bei Kindern im Alter ab 2 Jahren Businesswire
04-Feb-2023 Dentalis Animal Health appoints Advisory Board Businesswire
04-Feb-2023 La FDA américaine approuve TAKHZYRO® (lanadélumab-flyo) de Takeda pour prévenir les crises d’angioœdème héréditaire (AOH) chez les enfants de 2 ans et plus Businesswire
04-Feb-2023 NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Feb-2023 U.S. FDA Approves Takeda’s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older Businesswire
04-Feb-2023 Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies Businesswire
04-Feb-2023 Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
03-Feb-2023 Medidata Experts Present New Insights on Risk-Based Quality Management, Decentralized Clinical Trials, and Real World Data at SCOPE Summit Businesswire
03-Feb-2023 Promotions and Team Expansion Mark the Start of a New Year at Leason Ellis Businesswire
03-Feb-2023 FOXO Technologies Appoints Taylor Fay as Chief Operating Officer Businesswire
03-Feb-2023 Former NFL standout, Rob Sims, and Pro Football Hall of Fame Member, Calvin Johnson Jr., Launch Primitiv Performance™ Line of nano-CBD Products Businesswire